INTRODUCTION
Autoimmune diseases in general, and systemic lupus erythematosus (SLE)l in particular, are much more This work was presented, in part, at the 40th Annual Meeting of the American Rheumatism Association Section of the Arthritis Foundation, Chicago, Ill., June 1976. Receivedfor publication 20 September 1976 and in revised form 24 February 1977.
'Abbreviations used in this paper: B/W, NZB x NZW F1, hybrid mice; Poly A, polyadenylic acid; SLE, systemic lupus erythematosus. common in females than in males (1) . An explanation for this clinical difference is not readily apparent.
The availability of the NZB/NZW F1 (B/W) mouse as a model for SLE has permitted investigation of this question.
B/W mice spontaneously produce LE cells and antibodies to nucleic acids. They develop an immune complex glomerulonephritis associated with the deposition of DNA, immunoglobulin (particularly IgG), and complement (2) . Genetic, immunologic, and viral factors are all intimately involved in the pathogenesis of their disorder (3) . As in human lupus, there is a striking sex difference in the mouse disease. Female mice have an earlier onset and greater severity of immune complex nephritis compared to males. These pathologic features are associated with an earlier appearance of IgG antibodies to DNA and RNA (4) .
We have observed the ordered and sequential appearance of antibodies to DNA and polyadenylic acid (Poly A) in B/W mice (5) . As Hormone replacement To achieve a maintained hormone replacement in castrated females, a 2-cm silastic tubing containing 6-7 mg of either estrogen or androgen powder was implanted subcontaneously immediately after the castration procedure. This treatment results in a prompt establishment of an adequate hormone level reached within 12 h, which persists for at least 3 mo (Dr. P. Siiteri, personal communication). (Table III) .
Prepubertal castration caused a slight decrease in the magnitude of the anti-DNA response at 4 mo, but had no effect at 6 mo (Table III) . At 7 mo, there was less 7S binding of DNA in castrated females, while the 19S binding was unaffected (Table III) .
Poly A binding remained almost exclusively 19S post-castration. The expected 7S response to Poly A was markedly reduced at 6 mo and virtually absent at 7 mo (Table III) . By contrast, the 19S response at these ages was almost unchanged.
Development of antibodies to DNA and Poly A in castrated male BIW mice. Antibodies to DNA in sham-operated male B/W mice were less than in females and predominantly 19S (Table IV) . The switch to 7S antibodies to DNA occurred at 7 mo of age. Some 7S antibodies to Poly A appeared at 7 mo (Table IV) . The results in sham-operated males and females were generally comparable to data obtained previously in control, nonoperated B/W mice (5, 6) . The decrease in DNA binding in sham-operated males between 4 and 6 mo may be due to the formation of immune complexes, as noted previously (5) .
Prepubertal castration caused a proportionate in- (Table IV) .
Effects of sex hormone replacement on disease in castrated female BIW mice. Castrated female B/W mice were given subcutaneous implants containing either estrogen or androgen. Animals replaced with estrogen had a 94% mortality at 8 mo, compared to 14% in the female mice receiving androgen ( Table V) . The estrogen-treated mice had larger amounts of both 19S and 7S antibodies to DNA and Poly A when compared to the androgentreated mice. The most striking difference was in the 7S response to Poly A, which was greatly reduced in the mice receiving androgen (Table V) . Proteinuria ranged between 100 and 1,000 mg/ 100 ml in mice replaced with estrogen, and was less than 100 mg/100 ml in mice receiving androgen. In preliminary experiments, the kidneys of estrogentreated mice showed marked lymphocytic infiltration and glomerulonephritis, whereas the kidneys in animals receiving androgen showed minimal lymphocytic infiltration and glomerular changes.
DISCUSSION
The greater severity of autoimmune disease in female B/W mice (compared to males) seems es- There is more anti-DNA antibody formation in these female mice associated with an earlier switch to 7S antibody and accelerated appearance of severe lupus nephritis. We undertook this study to determine whether sex hormones influenced the disease expression in B/W mice, and if so, whether the predominant effect could be attributed to male or female hormones. In a previous study, Steinberg et al. (10) observed that castration of male B/IW mice at 5 wk produced a slight increase in DNA binding at 61/2 mo of age. In the present study, we have obtained evidence that androgens may play a major protective role.
The alteration in hormone status as a result of prepubertal castration was shown by the marked decline in serum testosterone concentration. These castrated males developed a disease pattern that resembled sham-operated females, associated with an increase in DNA and RNA binding, and an accelerated switch to 7S antibodies. 9 of 15 castrated males were dead prematurely by 8 mo of age.
By contrast, prepubertal castration of female B/W mice had no effect on life span and less effect on anti-nucleic acid antibodies. The only change in the DNA response was a modest decrease in 7S antibodies observed at 7 mo. However, there was a striking effect on the Poly A response. The anticipated switch to 7S antibodies was virtually eliminated by prepubertal castration, whereas the 19S antibodies were unaffected.
The results of our castration experiments are consistent with the known effects of androgens and estrogens on the normal immune response. Immtune Androgenic Hormones and Murine Lupusreactivity is generally enhanced in females compared to males (11 Our experiments offer an explanation for the greater incidence of lupus and other autoimmune diseases in females compared to males. They further suggest that autoimmunity may arise as a consequence of disordered immunologic regulation in which physiologic control mechanisms are still operative, albeit in a defective manner. The improved survival and disease manifestations in castrated female mice given androgen suggests that hormonal modulation of murine lupus may have important therapeutic possibilities. The preliminary observations are currently being investigated in a large study involving both castrated male and female mice given the same or opposite sex hormone, as well as mice subjected to androgen therapy during the course of established disease.
